Evidence map›Paper›PMID 26198291›Full record

ArticleAngiogenesis2015

Metallothionein 2 regulates endothelial cell migration through transcriptional regulation of vegfc expression.

Annika Schuermann, Christian S M Helker, Wiebke Herzog

Abstract read
In one paragraph

Article in Angiogenesis, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. The roles of metallothioneins in carcinogenesis.Journal of hematology & oncology · 2018
    Review
  17. MgClExperimental and therapeutic medicine · 2017
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Annika SchuermannUniversity of Muenster, Muenster, Germany.
Christian S M HelkerUniversity of Muenster, Muenster, Germany.
Wiebke HerzogUniversity of Muenster, Muenster, Germany. wiebke.herzog@mpi-muenster.mpg.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Analysis of developmental angiogenesis can help to identify regulatory networks, which also contribute to disease-related vascular growth. Vascular endothelial growth factors (Vegf) drive angiogenic processes such as sprouting, endothelial cell (EC) migration and proliferation. However, how Vegf expression is regulated during development is not well understood. By analyzing developmental zebrafish angiogenesis, we have identified Metallothionein 2 (Mt2) as a novel regulator of vegfc expression. While Metallothioneins (Mts) have been extensively analyzed for their capability of regulating homeostasis and metal detoxification, we demonstrate that Mt2 is required for EC migration, proliferation and angiogenic sprouting upstream of vegfc expression. We further demonstrate that another Mt family member cannot compensate Mt2 deficiency and therefore postulate that Mt2 regulates angiogenesis independent of its canonical Mt function. Our data not only reveal a non-canonical function of Mt2 in angiogenesis, but also propose Mt2 as a novel regulator of vegfc expression.

Indexed as

AnimalsCell MovementEndothelial CellsGene Expression Regulation, DevelopmentalMetallothioneinNeovascularization, PhysiologicTranscription, GeneticVascular Endothelial Growth Factor CZebrafishZebrafish ProteinsMetallothioneinVascular Endothelial Growth Factor Cvascular endothelial growth factor C, zebrafishZebrafish ProteinsAngiogenesisEndothelial cell migrationNonsense-mediated decayPhenotype variabilityTALENVegfcZebrafish

Identifiers

PMID26198291
PMCPMC4596909

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.